Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma
Clinical trial NCT01537861 · TERMINATED
Trial details
- NCT number
- NCT01537861
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2014-02-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.